Chronic pneumopathy secondary to swallowing disorder in a patient with mitochondrial myopathy
DOI:
https://doi.org/10.17533/udea.iatreia.26Keywords:
deglutition, deglutition disorders, lung diseases, mitochondrial diseases, mitochondrial myopathiesAbstract
Introduction: Chronic lung disease secondary to dysphagia is a frequent complication in patients with neuromuscular diseases. Mitochondrial myopathies could lead to progressive lung damage due to chronic aspiration syndrome.
Clinical case: Seven-year-old male with clinical and radiological signs of chronic lung disease, as well as low weight, weakness, dysphonia and multiplanar external oculoparesis. His father had similar symptoms during infancy and needed thickened liquid diet due to swallowing disorder. Dysphagia was confirmed as the cause of chronic lung disease and, therefore, hereditary congenital myopathy was suspected. Mitochondrial disease with chronic external oculoparesis was confirmed by molecular sequencing of the mitochondrial DNA gamma polymerase gene (POLG).
Conclusion: Neuromuscular disorders may cause chronic lung disease. Mitochondrial myopathy with progressive chronic external oculoparesis is associated with swallowing disorder in 50 % of the cases. Early diagnosis is important to slow decline in lung function.
Downloads
References
(1.) Bacco J, Araya F, Flores E, Peña N. Trastornos de la alimentación y deglución en niños y jóvenes portadores de parálisis cerebral: abordaje multidisciplinario. Rev. méd. Clín. 2014;25(2)330-42. DOI 10.1016/S0716-8640(14)70044-6.
(2.) García J. Disfagia en la infancia. An Pediatr Contin. 2014;12(5):221-30. DOI: 10.1016/S1696-2818(14)70195-7.
(3.) Henao P, Lopera M, Salazar O, Medina P, Morales O. Guía de práctica clínica basada en la evidencia para el diagnóstico de disfagia en niños. Iatreia. 2009;22(2):169-79.
(4.) Moënne K. Aporte del estudio por imágenes en el estudio de alteraciones respiratorias en niños con limitaciones neurológicas. Neumol Pediatr. 2011;6(2):75-9.
(5.) Cámpora H, Falduti A. Evaluación y tratamiento de las alteraciones de la deglución. Rev Am Med Resp. 2012;3:98-107.
(6.) Klopstock T, Jaksch M, Gasser T. Age and cause of death in mitochondrial diseases. Neurology. 1999;53(4):855-7.
(7.) Domenis DR, Granzotti RB, Sobreira CF, Dantas RO. Pharyngeal transit in patients with chronic progressive external ophthalmoplegia. Int J Speech Lang Pathol. 2015;17(4):384–9. DOI 10.3109/17549507.2014.941935.
(8.) Rebolledo F. Alimentación y deglución. Aspectos relacionados con el desarrollo normal. Plast & Rest Neurol. 2005;4(1-2):49-57.
(9.) Vincent AE, Rosa HS, Pabis K, Lawless C, Chen C, Grünewald A, et al. Sub-cellular origin of mtDNA deletions in human skeletal muscle. Ann Neurol. 2018 Jul 16;84(2):289-301 . DOI: 10.1002/ana.25288.
(10.) Neeve V, Samuels D, Bindoff A, Bosch B, Goethem G, Smeets H, et al. What is influencing the phenotype of the common homozygous polymerase-γ mutation p.Ala467Thr? Brain. 2012 Dec;135(12):3614-26. DOI 10.1093/brain/aws298.
(11.) Hsiao CC, Lee NC, Huang PH, Tsai TH. Histopathological and genetic analysis of extraocular muscle in chronic progressive external ophthalmoplegia. J Formos Med Assoc. 2016;115(11):1012-14. DOI 10.1016/j.jfma.2016.04.010.
(12.) Ringel SP, Wilson WB, Barden MT, et al. Extraocular muscle biopsy in chronic progressive external ophthalmoplegia. Ann Neurol. 1979;6(4):326-39. DOI 10.1002/ana.410060406.
(13.) Jiménez-Caballero PE, Serviá M , Cabeza CI, Marsal-Alonso C, Alvarez-Tejerina A, et al. Chronic progressive external ophthalmoplegia: clinical and electromyographic manifestations in a series of cases. Rev Neurol. 2006;43(12):16-31.
(14.) Smits B, Heijdra Y, Cuppen F, Van Engelen BG. Nature and frequency of respiratory involvement in chronic progressive external ophthalmoplegia. J Neurol. 2011;258(11):2020–5. DOI 10.1007/s00415-011-6060-7.
(15.) Steele HE, Horvath R, Lyon JJ, Chinnery PF. Monitoring clinical progression with mitochondrial disease biomarkers. Brain. 2017 Oct 1;140(10):2530-40. DOI 10.1093/brain/awx168.
(16.) Gehrig SM, Mihaylova V, Frese S, Mueller SM, Ligon-Auer M, Spengler CM, et al. Altered skeletal muscle (mitochondrial) properties in patients with mitochondrial DNA single deletion myopathy. Orphanet J Rare Dis. 2016 Jul 29;11(1):105. DOI 10.1186/s13023-016-0488-x.
(17.) Pfeffer G, Majamaa K, Turnbull DM, Thorburn D, Chinnery PF. Treatment for mitochondrial disorders. Cochrane Database Syst Rev. 2012;(4):CD4426. DOI 10.1002/14651858.CD004426.pub3.
(18.) Parikh S, Goldstein A, Koenig MK, Scaglia F, Enns GM, Saneto R, et al. Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet Med. 2015;17(9):689-701. DOI 10.1038/gim.2014.177.
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Universidad de Antioquia
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Papers published in the journal are available for use under the Creative Commons license, specifically Attribution-NonCommercial-ShareAlike 4.0 International.
The papers must be unpublished and sent exclusively to the Journal Iatreia; the author uploading the contribution is required to submit two fully completed formats: article submission and authorship responsibility.
